* Sanara Medtech Inc SMTI.OQ reported a quarterly adjusted
loss
of 42 cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 28 cents per
share.
* Revenue was $9.67 million; analysts expected $8.70
million.
* Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 42 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Sanara Medtech Inc shares had risen by 35.3% this
quarter and
lost 4.5% so far this year.
* The company reported a quarterly loss of $3.25 million.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $50.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 15
at 09:52 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.28 -0.42 Missed
Dec. 31 2021 -0.27 -0.48 Missed
Sep. 30 2021 -0.18 -0.27 Missed